Augmentin and Flector drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Flector (diclofenac epolamine). Common drug interactions include fatigue among females and pyrexia among males.
The phase IV clinical study analyzes what interactions people have when they take Augmentin and Flector. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.
What is Augmentin?
Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.
What is Flector?
Flector has active ingredients of diclofenac epolamine. It is often used in pain. eHealthMe is studying from 5,112 Flector users. Check the latest studies of Flector.
60 people who take Augmentin and Flector together, and have interactions are studied.

What are the common drug interactions of Augmentin and Flector, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Neck pain
- Pain in extremity
- Visual impairment
- Alopecia (absence of hair from areas of the body)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Chest pain
- Dehydration (dryness resulting from the removal of water)
- Delirium (wild excitement)
- Dementia (madness)
male:
- Pyrexia (fever)
- Leukocytosis (increased white blood cells)
- Skin exfoliation (removal of the oldest dead skin cells)
- Skin lesion
- Toxic skin eruption (skin breakdown due to toxic substance)
- Urinary tract infection staphylococcal
- Weight increased
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Intestinal perforation (complete penetration of the wall of the intestine)
What are the common drug interactions of Augmentin and Flector, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Headache (pain in head)
- Abdominal pain
- Activities of daily living impaired
- Arthralgia (joint pain)
- Asthenia (weakness)
- Chills (felling of cold)
- Conjunctivitis (pink eye)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Diarrhoea
- Drug intolerance (drug sensitivity)
50-59:
- General physical health deterioration (weak health status)
- Hyperthyroidism (over activity of the thyroid gland)
- Lung disorder (lung disease)
- Malignant neoplasm progression (cancer tumour came back)
- Mucosal inflammation (infection of mucous membrane)
- Nausea (feeling of having an urge to vomit)
- Neck pain
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Thrombocytopenia (decrease of platelets in blood)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
60+:
- Depression
- Fatigue (feeling of tiredness)
- Diarrhoea
- Dry mouth
- Dyspnoea (difficult or laboured respiration)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Hallucination (an experience involving the perception of something not present)
- Hyperhidrosis (abnormally increased sweating)
- Joint swelling
- Muscular weakness (muscle weakness)
What are the existing conditions these people have? *
- Pneumonia: 9 people, 15.00%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 13.33%
- Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 11.67%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 11.67%
- Depression: 7 people, 11.67%
- High Blood Pressure: 6 people, 10.00%
- Asthma: 5 people, 8.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 8.33%
- Lung Disorder (lung disease): 5 people, 8.33%
- Lung Infection: 5 people, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Augmentin and Flector?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Augmentin and Flector:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Augmentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Flector:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Augmentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flector and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and diclofenac epolamine (the active ingredients of Augmentin and Flector, respectively), and Augmentin and Flector (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cyclobenzaprine Hydrochloride cause Face Oedema? - 2 seconds ago
- Drug interactions of Clonidine Hydrochloride and Divalproex Sodium - 3 seconds ago
- Could Lorcet-Hd cause Bursitis? - 4 seconds ago
- Could Loraz cause Blood Pressure Systolic Increased? - 8 seconds ago
- Could Cozaar cause Generalised Erythema? - 15 seconds ago
- Could Loraz cause Mycobacterium Tuberculosis Complex Test Positive? - 15 seconds ago
- Could Fingolimod Hydrochloride cause Movement - Uncoordinated? - 22 seconds ago
- Drug interactions of Clobetasol Propionate and Valsartan - 26 seconds ago
- Could Guaifenesin cause Blood Albumin Decreased? - 27 seconds ago
- Could Ritalin cause Faeces Discolored? - 30 seconds ago